What is the appropriate dose of amoxicillin/clavulanate (Augmentin) for a geriatric patient with creatinine clearance below 30 mL/min?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Augmentin Dosing in Geriatric Patients with CrCL <30 mL/min

For geriatric patients with creatinine clearance below 30 mL/min, reduce the Augmentin dosing interval rather than the individual dose: give 250-500 mg every 12 hours for CrCL 10-30 mL/min, or 250-500 mg every 24 hours for CrCL <10 mL/min or patients on hemodialysis.

Dosing Algorithm Based on Renal Function

The FDA label does not provide explicit geriatric renal dosing for oral Augmentin 1, but the pharmacokinetic principles are clear from research data:

For CrCL 10-30 mL/min:

  • Standard approach: 250-500 mg every 12 hours
  • Amoxicillin half-life extends from ~1 hour (normal function) to 7-9 hours in severe renal impairment 2, 3
  • The drug is primarily renally cleared (68% urinary recovery) 2

For CrCL <10 mL/min or Hemodialysis:

  • 250-500 mg every 24 hours
  • Give an additional dose after each dialysis session (amoxicillin half-life during hemodialysis is 2.3-3.6 hours) 2, 3
  • Hemodialysis removes significant amounts of both amoxicillin and clavulanate

Critical Considerations for Elderly Patients

Elderly patients have 90% higher amoxicillin exposure and 60% higher clavulanate exposure compared to younger adults, even with normal age-adjusted renal function 4. This means:

  • Use the lower end of dosing ranges (250 mg rather than 500 mg) initially
  • Monitor closely for adverse effects, particularly gastrointestinal symptoms (15% higher risk with amoxicillin-clavulanate) 4, 5
  • The Cockcroft-Gault equation is the most accurate predictor of antibiotic clearance in this population (R² = 0.35) 6

Practical Dosing Recommendations

Starting regimen for most geriatric patients with CrCL <30 mL/min:

  • Augmentin 250 mg PO every 12 hours (for CrCL 10-30)
  • Augmentin 250 mg PO every 24 hours (for CrCL <10)

For more severe infections requiring higher doses:

  • Augmentin 500 mg PO every 12 hours (for CrCL 10-30)
  • Augmentin 500 mg PO every 24 hours (for CrCL <10)

Common Pitfalls to Avoid

  1. Don't rely on serum creatinine alone - elderly patients often have normal creatinine despite significantly reduced GFR due to decreased muscle mass 7. Always calculate CrCL using Cockcroft-Gault equation.

  2. Don't substitute formulations - The 200 mg/5 mL and 400 mg/5 mL suspensions contain different amounts of clavulanate and are not interchangeable 1.

  3. Monitor for accumulation - The linear relationship between amoxicillin half-life and creatinine clearance (r = 0.967) means even small changes in renal function significantly impact drug levels 2.

  4. Hepatic monitoring - Hepatically impaired patients require dose caution and regular monitoring 1, particularly relevant in elderly with multiple comorbidities.

  5. Increased adverse event risk - Elderly patients have higher rates of gastrointestinal symptoms (RR 1.15) and yeast infections (RR 1.33) with amoxicillin-clavulanate 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.